Strong Emerging Rationale for Combining Oncogene-Targeted Agents With Immunotherapy

OncoImmunology - United States
doi 10.4161/onci.22730
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Combining Immunotherapy With Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

Frontiers in Immunology
AllergyImmunology
2015English

Combining Targeted Therapy With Immunotherapy inBRAF-Mutant Melanoma: Promise and Challenges

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Combining Emerging Agents in Advanced Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2011English

Targeted Therapy and Immunotherapy: Emerging Biomarkers in Metastatic Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2020English

Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma

OncoImmunology
OncologyAllergyImmunology
2013English

Tumor Targeted Nanocarriers for Immunotherapy

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2020English

Emerging Nano-/Microapproaches for Cancer Immunotherapy

Advanced Science
Materials ScienceGeneticsMolecular BiologyBiochemistryEngineeringChemical EngineeringMedicineAstronomyPhysics
2019English

Combining Immunotherapy With Radiation Therapy in Thoracic Oncology

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Clinical Opportunities in Combining Immunotherapy With Radiation Therapy

Frontiers in Oncology
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy